Renaissance Technologies’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Sell |
|
|||||
|
2025
Q1 | $3.33M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $270K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $393K | Buy |
|
|||||
|
2023
Q2 | $128K | Sell |
|
|||||
|
2023
Q1 | $375K | Sell |
|
|||||
|
2022
Q4 | $826K | Buy |
|
|||||
|
2022
Q3 | $61K | Sell |
|
|||||
|
2022
Q2 | $1.53M | Sell |
|
|||||
|
2022
Q1 | $2.53M | Buy |
|
|||||
|
2021
Q4 | $558K | Sell |
|
|||||
|
2021
Q3 | $2.46M | Sell |
|
|||||
|
2021
Q2 | $4.64M | Buy |
|
|||||
|
2021
Q1 | $819K | Sell |
|
|||||
|
2020
Q4 | $6.92M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $825K | Sell |
|
|||||
|
2016
Q4 | $1.21M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $234K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $231K | Buy |
|